Expensify's 250% New-Business Surge Just Dropped-Now Investors Must Separate Real Momentum from FOMO

Expensify's Q2 raised the bar, but the stock is already trading the narrative

After yesterday's Q2 earnings call, EXFY was quoting at a $1.56 premarket price. That tells you the market is reacting to the rerating story as much as to the quarter itself.

The operating results support that attention. Expensify reported $33.9 million of Q2 revenue and raised full-year 2026 free cash flow guidance to $12 million-$14 million from $6 million-$9 million. It also generated $6.4 million of free cash flow in the quarter. For investors, that is the real split in the tape: strong cash conversion and a much more optimistic full-year setup.

The risk is that the market starts pricing the upside before the transition is fully proven. The quarter showed Expensify can still generate cash; the next few quarters have to show that the higher guidance range is sustainable.

New Expensify is becoming a real revenue stream, not just a promise

Net-new ARR is the clearest sign the product handoff is working

New Expensify now contributes more than $10 million ARR from net new customers after growing more than 250% year over year. That matters because this is not legacy renewal revenue. It is revenue from buyers who never used Classic, which suggests the new product is becoming a genuine acquisition engine rather than a side project.

Profitability is improving alongside the growth story

Expensify posted a GAAP net loss of $3.9 million versus $8.8 million year ago and non-GAAP net income of $3.4 million, while also generating $6.4 million of free cash flow. That combination makes the turnaround case more credible. Management is no longer asking investors to imagine better economics; the quarter showed them.

The card business keeps the valuation story open

Interchange revenue grew 12% to $5.9 million, showing the card program is still scaling even as Expensify promotes a bring-your-own-card motion. If investors start viewing the company less as a legacy expense tool and more as a workflow platform with embedded finance, that can support a higher multiple over time.

The buyback helped the per-share math, but it did not settle the core debate

Expensify repurchased 6.8 million shares in Q2, producing about a 7% reduction in shares outstanding. That is meaningful in a stock of this size. It reduces the denominator and signals that management sees value in owning back equity.

But the buyback also highlights what still needs proof. The central question is not whether fewer shares can support the stock; it is how quickly New Expensify can outgrow Classic churn. Buybacks can improve per-share economics, but they do not replace the need for durable new-business momentum.

What the repurchase mix suggests

Management bought 6.1 million shares at $1.20 through the tender and added open-market shares afterward. That suggests price sensitivity as well as willingness to keep buying, but it does not answer the operating question at the center of the bull-bear debate: whether the new-product surge is becoming strong enough to offset legacy drag without leaning so heavily on capital allocation.

What would confirm the rerating-and what would expose it too early

The market is already giving Expensify credit for the guidance raise and the share reduction. What still needs confirmation is whether the new-business surge can keep improving the quality and stability of the base. The clearest test is whether management keeps drifting toward the upper end of its raised free cash flow guidance while showing that July paid members no longer look like a low point.

Signals that would support the bullish case

• Paid-member trends stabilize or improve from July onward.
• Interchange momentum holds from 12% interchange growth.
• Repurchases continue to be supported by cash generation rather than optics alone.

Signals that would warn the rally is getting ahead of itself

• Paid members continue to slide.
• Card growth cools from its recent $5.9 million interchange revenue pace.
• Buybacks start to look like a substitute for durable operating improvement.

The cleanest takeaway is simple: the quarter improved the story, but the next few quarters have to validate it. For investors, the edge is in waiting for confirmation on members, cash flow, and card momentum rather than paying up for a rerating before the evidence is fully there.